CeNeS Pharmaceuticals Overview

  • Founded
  • 1996
  • Status
  • Acquired/​Merged
  • Employees
  • 12
  • Latest Deal Type
  • M&A

CeNeS Pharmaceuticals General Information


Operator of a drug development company. The company engages in discovering drug products for the treatment of central nervous system disorders.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Compass House, Vision Park
  • Histon
  • Cambridge CB24 9ZR
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CeNeS Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 23-Jun-2008 00.00 Completed Generating Revenue
3. 2PO 08-Aug-2003 00.000 00.00 Completed Generating Revenue
2. Early Stage VC $6.52M Completed Startup
1. Early Stage VC 23-Apr-1997 $6.52M $6.52M 000.00 Completed Startup
To view CeNeS Pharmaceuticals’s complete valuation and funding history, request access »

CeNeS Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CeNeS Pharmaceuticals Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Alice Ventures Venture Capital Minority 000 0000 000000 0
Avlar BioVentures Venture Capital Minority 000 0000 000000 0
Prelude Ventures (Cambridge) Venture Capital Minority 000 0000 000000 0
To view CeNeS Pharmaceuticals’s complete investors history, request access »